Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,233 | 23,000 | 28,980 | 31,860 | 28,867 |
| Marketable Securities | 13,641 | 5,795 | 6,375 | 6,090 | 6,383 |
| Receivables | 1,597 | 2,023 | 1,830 | 2,657 | 2,293 |
| Inventories | 249 | 591 | 566 | 165 | 162 |
| TOTAL | $35,720 | $31,409 | $37,751 | $40,772 | $37,705 |
| Non-Current Assets | |||||
| PPE Net | 2,589 | 2,651 | 2,499 | 2,571 | 2,495 |
| Investments And Advances | 53 | 74 | 74 | 21 | 24 |
| Intangibles | 13,659 | 13,901 | 14,140 | 14,385 | 14,630 |
| Other Non-Current Assets | 1,319 | 1,440 | 1,662 | 1,639 | 1,808 |
| TOTAL | $17,620 | $18,066 | $18,375 | $18,616 | $18,957 |
| Total Assets | $53,340 | $49,475 | $56,126 | $59,388 | $56,662 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,405 | 2,171 | 2,653 | 1,921 | 2,261 |
| Accrued Expenses | 2,159 | 2,042 | 1,987 | 2,324 | 2,384 |
| Other current liabilities | 541 | 209 | 79 | 94 | 126 |
| TOTAL | $6,391 | $5,356 | $5,625 | $5,583 | $5,541 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 392 | 30 | 22 | 360 | 16 |
| Other Non-Current Liabilities | 16,595 | 16,334 | 16,534 | 16,126 | 6,657 |
| TOTAL | $15,840 | $15,624 | $15,711 | $15,507 | $5,724 |
| Total Liabilities | $22,231 | $20,980 | $21,336 | $21,090 | $11,265 |
| Shareholders' Equity | |||||
| Common Shares | 237 | 237 | 235 | 234 | 234 |
| Retained earnings | -247,001 | -239,978 | -233,707 | -230,709 | -224,165 |
| Other shareholders' equity | 16,821 | 6,406 | 6,860 | 7,721 | 8,448 |
| TOTAL | $31,109 | $28,495 | $34,790 | $38,298 | $45,397 |
| Total Liabilities And Equity | $53,340 | $49,475 | $56,126 | $59,388 | $56,662 |